» Articles » PMID: 25242986

Comparison of Conventional IVF Versus ICSI in Non-male Factor, Normoresponder Patients

Overview
Date 2014 Sep 23
PMID 25242986
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conventional IVF and ICSI are two common techniques to achieve fertilization. IVF has long been used for treatment of infertility, although it is not an effective treatment in severe male infertility. The use of ICSI has been expanded in severe male factor and fertilization failure after IVF cycle. In spite of the widespread use of ICSI in patients with non-male factor infertility, there is still little evidence to confirm its effectiveness in this population.

Objective: To evaluate assisted reproductive technology outcomes between IVF and ICSI cycles in non-male factor, normoresponder patients.

Materials And Methods: A total of 220 non-male factors, normoresponder patients who were indicated for ART were enrolled in this study. The patients received standard long GnRH agonist or GnRH antagonist protocols for ovarian stimulation and after oocytes retrieval, the patients were divided into two groups (IVF and ICSI groups). In IVF group (n=112), all of retrieved oocytes were treated by conventional IVF and in ICSI group (n=88), microinjection (ICSI) was done on all of retrieved oocytes.

Results: In IVF group, fertilization and implantation rates were significantly higher than ICSI group (66.22% and 16.67% in IVF group versus 57.46% and 11.17% in ICSI group, respectively). Chemical and clinical pregnancy rates were statistically higher in IVF group as compared with the ICSI group (42.9% vs. 27.3% and 35.7% vs. 21.5%, respectively).

Conclusion: According to our study, the routine use of ICSI is not improved fertilization, implantation and chemical pregnancy rates and is not recommended in non-male factor, normozoospermic patients.

Citing Articles

Making immotile sperm motile using high-frequency ultrasound.

Vafaie A, Raveshi M, Devendran C, Nosrati R, Neild A Sci Adv. 2024; 10(7):eadk2864.

PMID: 38354240 PMC: 10866541. DOI: 10.1126/sciadv.adk2864.


Evaluation of the expression profile of mRNAs and lncRNAs in cumulus cells associated with polycystic ovary syndrome and pregnancy.

Hammami B, Mostafavi F, Akbari A, Mousavi S, Kazemi M Iran J Basic Med Sci. 2023; 26(10):1144-1154.

PMID: 37736513 PMC: 10510482. DOI: 10.22038/IJBMS.2023.67564.14806.


Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility.

Cutting E, Horta F, Dang V, van Rumste M, Mol B Cochrane Database Syst Rev. 2023; 8:CD001301.

PMID: 37581383 PMC: 10426261. DOI: 10.1002/14651858.CD001301.pub2.


A Dual Architecture Fusion and AutoEncoder for Automatic Morphological Classification of Human Sperm.

Mahali M, Leu J, Darmawan J, Avian C, Bachroin N, Prakosa S Sensors (Basel). 2023; 23(14).

PMID: 37514907 PMC: 10385996. DOI: 10.3390/s23146613.


The Sperm DNA Fragmentation Assay with SDF Level Less Than 15% Provides a Useful Prediction for Clinical Pregnancy and Live Birth for Women Aged under 40 Years.

Chua S, Yovich S, Hinchliffe P, Yovich J J Pers Med. 2023; 13(7).

PMID: 37511693 PMC: 10381567. DOI: 10.3390/jpm13071079.


References
1.
. Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. Hum Reprod Update. 2007; 13(6):515-26. DOI: 10.1093/humupd/dmm024. View

2.
Devroey P, VAN Steirteghem A . A review of ten years experience of ICSI. Hum Reprod Update. 2004; 10(1):19-28. DOI: 10.1093/humupd/dmh004. View

3.
Oehninger S, Gosden R . Should ICSI be the treatment of choice for all cases of in-vitro conception? No, not in light of the scientific data. Hum Reprod. 2002; 17(9):2237-42. DOI: 10.1093/humrep/17.9.2237. View

4.
Gozlan I, Dor A, Farber B, Meirow D, Feinstein S, Levron J . Comparing intracytoplasmic sperm injection and in vitro fertilization in patients with single oocyte retrieval. Fertil Steril. 2006; 87(3):515-8. DOI: 10.1016/j.fertnstert.2006.07.1515. View

5.
Ola B, Afnan M, Sharif K, Papaioannou S, Hammadieh N, Barratt C . Should ICSI be the treatment of choice for all cases of in-vitro conception? Considerations of fertilization and embryo development, cost effectiveness and safety. Hum Reprod. 2001; 16(12):2485-90. DOI: 10.1093/humrep/16.12.2485. View